Skip to main content
Log in

Injektion nur alle 8 Wochen erforderlich

Neue Realität in der HIV-Therapie: Langwirksame, injizierbare Medikamente

New reality in HIV therapy: Long-acting, injectable drugs

  • FB_Schwerpunkt-Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

© ViiV Healthcare Group of Companies or its licensor, m. freundl. Gen.

Abb. 2

© C. Jonsson-Oldenbüttel, E. Wolf

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Celia Oldenbuettel.

Ethics declarations

CJO: Honorare für Vorträge/Advisory Boards, Kongressunterstützung von AbbVie, Gilead Sciences, Janssen-Cilag und ViiV Healthcare/GSK.

EW: Honorare für Vorträge/Advisory Boards, Kongressunterstützung von AbbVie, Biogen, Gilead Sciences, Janssen-Cilag, ViiV Healthcare/GSK und MSD Sharp&Dohme.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oldenbuettel, C., Wolf, E. Neue Realität in der HIV-Therapie: Langwirksame, injizierbare Medikamente. MMW - Fortschritte der Medizin 164 (Suppl 2), 44–51 (2022). https://doi.org/10.1007/s15006-022-1020-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-022-1020-y

Keywords:

Navigation